Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure)

American Journal of Cardiology

Volumn 92, Issue 4, 2003, Pages 478-480

  Goldstein, Sidney ^a   Deedwania, Prakash ^b   Gottlieb, Stephen ^b   Wikstrand, John ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0042063780     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00674-X     Document Type: Article

References (4)

1. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
2. Hjalmarson Å., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., Allaf D.E., Vítovec J., Aldershvile J., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well being in patients with heart failure. The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA. 283:2000;1295-1302.
3. Yancy C.W., Fowler M.B., Colucci W.S., Gilbert E.M., Bristow M.R., Cohn J.N., Lukas M.A., Young S.T., Packer M. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med. 344:2001;1358-1365.
4. A trial of the β-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 344:2001;1659-1667.